• Careers
  • Contact Us

Gene Discovery from Breast Cancer Research shows Potential of Personalised Medicine in Cancer Prevention

on Friday, 20 May 2016.

New research from the Wellcome Trust Sanger Institute analysing the genomes of breast cancer tissue from over 500 patients...

...has found that there are 93 genes (including a further five previously unknown genes) in which a mutation could cause the development of breast cancer.

It is hoped that by analysing how these genes mutate into cancerous tissue will lead to gene profiling, which is capable of identifying the best treatments for patients diagnosed with breast cancer. Ultimately, this is a step towards personalised healthcare for treating cancer.

The development of patient pathways unique to each patient's genetic mutation is an exciting new development in the battle against cancer, and highlights the importance of gene discovery and analysis in developing new treatments, or enhancing the success rate for existing treatments, for cancer patients.


For more information, please contact Laura Barrell in our Pharmaceutical Law and Life Sciences team on 01923 919 313.

Leave a comment

You are commenting as guest.